Advocacy intelligence hub — real-time data for patient organizations
University Hospital, Clermont-Ferrand — NA
Avidity Biosciences, Inc. — PHASE3
National Institutes of Health Clinical Center (CC)
Ain Shams University
Avidity Biosciences, Inc. — PHASE3
OTEZLA®: FDA approved
OTEZLA is indicated for the treatment of adult patients with oral ulcers associated with Beh®et®s Disease.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
OTEZLA�
Amgen Inc.
OTEZLA�
(apremilast)Orphan drugAmgen Inc.
Phosphodiesterase 4 Inhibitor [EPC]
12.1 Mechanism of Action Apremilast is an oral small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAM...